BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35201622)

  • 21. Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors.
    Schwartz MD; Peshkin BN; Isaacs C; Grisham C; Holmes NJ; Sorgen LJ; Collins S; Dawson N; McGuire C; Okobi T; Newell K; Kolla KA; Weinstein V
    J Natl Compr Canc Netw; 2023 Dec; 21(12):1261-1268.e14. PubMed ID: 38081141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
    Breen KE; Symecko H; Spielman K; Gebert R; Shah IH; Pundock S; Batson M; Narayan VK; Stadler ZK; Autio KA; Abida W; Danila DC; Scher HI; Morris MJ; Hamilton JG; Robson ME; Domchek SM; Carlo MI
    J Urol; 2023 May; 209(5):918-927. PubMed ID: 36974724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
    Greenberg S; Slager S; Neil BO; Cooney K; Maughan B; Stopa N; Venne V; Zickmund S; Colonna S
    Prostate; 2020 Apr; 80(5):441-450. PubMed ID: 32027768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic Prostate Cancer: Effects of Genetic Testing on Care.
    Connors LM
    Clin J Oncol Nurs; 2019 Feb; 23(1):32-35. PubMed ID: 30681994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
    Harris JN; Bowen DJ; Kuniyuki A; McIntosh L; FitzGerald LM; Ostrander EA; Stanford JL
    Genet Med; 2009 May; 11(5):344-55. PubMed ID: 19346959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer.
    Borno HT; Odisho AY; Gunn CM; Pankowska M; Rider JR
    Urol Oncol; 2021 Apr; 39(4):233.e9-233.e14. PubMed ID: 33158741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer Patients.
    Suri Y; Yasmeh JP; Basu A
    Cancer Treat Res Commun; 2022; 32():100588. PubMed ID: 35759831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline Mutations and Ancestry in Prostate Cancer.
    Bataba E; Babcock K; Isensee KA; Eldhose B; Kohaar I; Chesnut GT; Dobi A
    Curr Oncol Rep; 2024 Feb; 26(2):175-180. PubMed ID: 38265515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations and prostate cancer: is it time to change treatment algorithms?
    Telvizian T; Mukherji D
    Chin Clin Oncol; 2020 Oct; 9(5):65. PubMed ID: 32921062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
    Beebe-Dimmer JL; Kapron AL; Fraser AM; Smith KR; Cooney KA
    J Clin Oncol; 2020 Jun; 38(16):1807-1813. PubMed ID: 32208047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Insights on Genetic Testing in Primary Prostate Cancer.
    Kafka M; Surcel C; Heidegger I
    Mol Diagn Ther; 2021 Jul; 25(4):425-438. PubMed ID: 34118026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
    Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
    Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
    Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic education and practice considerations of non-genetic providers.
    Giri VN
    Can J Urol; 2019 Oct; 26(5 Suppl 2):44-45. PubMed ID: 31629430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
    Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
    BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary prostate cancer: clinical aspects.
    Bratt O
    J Urol; 2002 Sep; 168(3):906-13. PubMed ID: 12187189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
    Abusamra SM; Solorzano MA; Luke M; Quarles J; Jacobs MF; Das S; Kasputis A; Okoth LA; Patel M; Seymore M; Caram MEV; Dunn RL; Merajver SD; Stoffel EM; Reichert ZR; Morgan TM
    J Urol; 2022 Nov; 208(5):1007-1017. PubMed ID: 35930793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.